A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.
Advertisement
The Scientist
Most Recent
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
Some of these insidious viruses expertly subvert the host immune system, allowing their unhindered proliferation.
Patient safety is paramount in regulating new stem cell treatments.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
After undergoing untested cosmetic surgery that uses stem cells to rejuvenate skin, a woman grew bone fragments in the flesh around one of her eyes.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
